Inhibition of Mutated BRAF in Melanoma.

被引：0
|
作者：
Kim, Taegyun [1 ]
Kim, Jihyun [1 ]
Lee, Min-Geol [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 363卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2261 / 2261
页数：1
相关论文
共 50 条
  • [21] Preclinical testing supports combined BET and BRAF inhibition as a promising therapeutic strategy for melanoma.
    Paoluzzi, Luca
    Hanniford, Douglas
    Sokolova, Elena
    Dolgalev, Igor
    Heguy, Adriana
    Osman, Iman
    Darvishian, Farbod
    Wang, Jinhua
    Bradner, James E.
    Hernando, Eva
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] BRAF mutation as a pejorative marker in metastatic melanoma.
    Brissy, Sophie
    Gaudy-Marqueste, Caroline
    Mallet, Stephanie
    Monestier, Sandrine
    Hesse, Sylvie
    Koeppel, Marie-Christine
    Rojat-Habib, Marie-Christine
    Nanni, Isabelle
    Loundou, Anderson
    Ouafik, L'houcine
    Bonnet, Nathalie
    Richard, Marie-Aleth
    Grob, Jean Jacques
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Neurological benefit of BRAF-inhibition and MEK-inhibition in patients with brain metastases from BRAF-mutated melanoma
    Foppen, M. Geukes
    Boogerd, W.
    Blank, C.
    Haanen, J. B. A. G.
    van Thienen, J. V.
    Brandsma, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Radiosensitizing effect of BRAF inhibitors in BRAF-mutated melanoma
    Hecht, M.
    Grabenbauer, M.
    Fietkau, R.
    Distel, L. V.
    Heinzerling, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 35 - 35
  • [25] Mechanisms of Resistance in BRAF Mutated Melanoma to BRAF-MEK Inhibition Revealed by Single Cell RNA Sequencing
    Krasnick, B. A.
    Yao, L.
    Sethuraman, S.
    Bi, Y.
    Goedegebuure, S. P.
    Ding, L.
    Fields, R.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S137 - S138
  • [26] Inhibition of glucose metabolism through treatment of BRAF mutated metastatic melanoma with vemurafenib.
    Warrier, Govind
    Lanceta, Lilibeth
    Imbert-Fernandez, Yoannis
    Chesney, Jason Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] VemurafenibTargeted Inhibition of Mutated BRAF for Treatment of Advanced Melanoma and Its Potential in Other Malignancies
    Anant Sharma
    Sachin R. Shah
    Henrik Illum
    Jonathan Dowell
    Drugs, 2012, 72 : 2207 - 2222
  • [28] Combination of RAF and MEK Inhibition for the Treatment of BRAF-Mutated Melanoma: Feedback Is Not Encouraged
    Chapman, Paul B.
    Solit, David B.
    Rosen, Neal
    CANCER CELL, 2014, 26 (05) : 603 - 604
  • [29] Prognostic role of BRAF mutation in malignant cutaneous melanoma.
    Sehdev, Amikar
    Hayden, Ross
    Kuhar, Mathew Joseph
    Cheng, Liang
    Warren, Simon John
    Mark, Lawrence Aaron
    Wooden, William Arthur
    Schwartzentruber, Douglas Jay
    Logan, Theodore F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Vemurafenib and cobimetinib in BRAF-mutated melanoma
    Rahman, Ahmadur
    LANCET ONCOLOGY, 2014, 15 (12): : E535 - E535
12345